Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort

被引:9
作者
Clausen, Louise Nygaard [1 ,2 ,3 ]
Weis, Nina
Schonning, Kristian [4 ]
Fenger, Mogens [5 ]
Krarup, Henrik [6 ,7 ]
Bukh, Jens [1 ,2 ,3 ]
Benfield, Thomas [2 ]
机构
[1] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen Hepatitis Program CO HEP C, DK-2650 Hvidovre, Denmark
[2] Copenhagen Univ Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark
[5] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark
[6] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Biochem, Aarhus, Denmark
[7] Aarhus Univ Hosp, Aalborg Hosp, Dept Med Gastroenterol, Aarhus, Denmark
基金
英国医学研究理事会;
关键词
Hepatitis C virus; HIV; hepatitis B virus; spontaneous HCV clearance; route of transmission; HIV-INFECTED PATIENTS; INJECTION-DRUG USERS; VIRAL LOAD; RECOVERED CHIMPANZEES; HCV; RESPONSES; REPLICATION; RECHALLENGE; PREVALENCE;
D O I
10.3109/00365548.2011.589077
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Around a quarter of individuals infected with hepatitis C virus (HCV) are spontaneously able to clear the virus. Correlates of spontaneous HCV clearance are not well established and the aim of this study was to characterize factors associated with spontaneous HCV clearance in a human immunodeficiency virus (HIV)-co-infected cohort. Methods: We analyzed 327 anti-HCV-positive HIV-1-infected patients using multivariate logistic regression. HCV clearance was defined as the presence of anti-HCV with undetectable HCV RNA from at least 2 measurements more than 6 months apart. Results: We included 327 HIV-1-infected individuals, predominantly of Caucasian race; 112 (34%) were females, 258 (79%) were injecting drug users (IDU), 25 (8%) were men who have sex with men (MSM), and 20 (6%) were hepatitis B surface antigen (HBsAg)-positive. Seventy-six (23%; 95% confidence interval (CI) 18-28) had cleared their HCV infection and 251 (77%; 95% CI 72-82) had a chronic infection. The clearance rate in HBsAg-positive individuals was 65%. Being female, HBsAg-positive, or belonging to HIV exposure groups IDU and MSM predicted higher HCV clearance rates (adjusted odds ratio (aOR) 1.8, 95% CI 1-3.2; aOR 7.6, 95% CI 2.7-21; aOR 5.2, 1.2-23.5; and aOR 10.2, 95% CI 1.8-58, respectively). Race, acquired immunodeficiency syndrome (AIDS), and antiretroviral therapy were not associated with HCV clearance. Conclusions: The HCV clearance rate in this HIV-1 cohort was 23%. MSM and IDUs may have higher clearance rates due to their repeated exposure to low-dose HCV, leading to immune memory. Our data suggest an interaction of hepatitis B virus and HCV that influences the outcome of acute HCV infection.
引用
收藏
页码:798 / 803
页数:6
相关论文
共 29 条
[1]   Spontaneous hepatitis C virus clearance in HIV-infected patients: New insights for improving management [J].
Bruno, Raffaele ;
Sacchi, Paolo .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (09) :1262-1264
[2]   Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Orland, J ;
Murphy, EL ;
Wright, DJ ;
Kleinman, S .
TRANSFUSION, 2006, 46 (03) :469-475
[3]   Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort [J].
Clausen, L. N. ;
Weis, N. ;
Astvad, K. ;
Schonning, K. ;
Fenger, M. ;
Krarup, H. ;
Bukh, J. ;
Benfield, T. .
JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) :e66-e74
[4]   Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV [J].
Deterding, Katja ;
Tegmeyer, Bjoern ;
Cornberg, Markus ;
Hadem, Johannes ;
Potthoff, Andrej ;
Boeker, Klaus H. W. ;
Tillmann, Hans L. ;
Manns, Michael P. ;
Wedemeyer, Heiner .
JOURNAL OF HEPATOLOGY, 2006, 45 (06) :770-778
[5]   Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses [J].
Garfein, RS ;
Vlahov, D ;
Galai, N ;
Doherty, MC ;
Nelson, KE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :655-661
[6]   Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses [J].
Gottwein, Judith M. ;
Scheel, Troels K. H. ;
Hoegh, Anne M. ;
Lademann, Jacob B. ;
Eugen-Olsen, Jesper ;
Lisby, Gorm ;
Bukh, Jens .
GASTROENTEROLOGY, 2007, 133 (05) :1614-1626
[7]   Noncytolytic control of viral infections by the innate and adaptive immune response [J].
Guidotti, LG ;
Chisari, FV .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :65-91
[8]   Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study [J].
Hansen, N. ;
Obel, N. ;
Christensen, P. B. ;
Krarup, H. ;
Laursen, A. L. ;
Clausen, M. R. ;
Lunding, S. ;
Moller, A. ;
Schlichting, P. ;
Kromann-Andersen, H. ;
Bukh, J. ;
Weis, N. .
JOURNAL OF VIRAL HEPATITIS, 2009, 16 (09) :659-665
[9]   Course and outcome of hepatitis C [J].
Hoofnagle, JH .
HEPATOLOGY, 2002, 36 (05) :S21-S29
[10]   Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection [J].
Jacobson, Ira M. ;
Davis, Gary L. ;
El-Serag, Hashem ;
Negro, Francesco ;
Trepo, Christian .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (11) :924-933